In vivo metabolic imaging reveals mitochondrial membrane potential reprogramming following Her2-targeted therapy and dormant disease

Conference Paper

We performed in intravital fluorescent microscopy in a preclinical cancer dormancy model to capture key changes in mitochondrial activity associated with Her2 treated breast cancer both acutely and in a residual disease state.

Duke Authors

Cited Authors

  • Madonna, MC; Duer, J; Fox, D; Alvarez, J; Ramanujam, N

Published Date

  • January 1, 2020

Published In

  • Optics Infobase Conference Papers

Volume / Issue

  • Part F178-Translational-2020 /

International Standard Book Number 13 (ISBN-13)

  • 9781557528209

Citation Source

  • Scopus